Publications
1,817
Citations
62,190
Est. group size
~4
Recurring co-author estimate
Active years
40
Publishing since 1987
Typically publishes in teams of ~12 · 2% small-team papers (≤3 authors) · across 113 venues
- Supplementary Figure S4 from Exploring B7-H4’s Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities
2026
- Supplementary Figure S3 from Exploring B7-H4’s Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities
2026
- Supplementary Figure S1 from Exploring B7-H4’s Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities
2026
- Supplementary Figure S2 from Exploring B7-H4’s Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities
2026
- Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer
New England Journal of Medicine · 2025
- Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study
European Urology · 2025
- CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of REST
Cell Genomics · 2025
- The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
Cell Reports · 2025
- New frontiers in prostate cancer treatment from systemic therapy to targeted therapy
EMBO Molecular Medicine · 2025
- Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer
Proceedings of the National Academy of Sciences · 2025
- Developing novel Lin28 inhibitors by computer aided drug design
Cell Death Discovery · 2025
- Exploring B7-H4’s Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities
Molecular Cancer Research · 2025
- DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer
Molecular Therapy · 2025
- Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial
The Journal of Urology · 2025
- BPTF regulates androgen receptor activity by enhancing chromatin accessibility and stabilizing the AR-FOXA1 interaction
Nature Communications · 2025
- Journal of Clinical Oncology×70
- The Journal of Urology×47
- Cancer Research×36
- European Urology×30
- Annals of Oncology×15
- Joshi J. Alumkal
Medicine · University of Michigan
- Elizabeth W. LaPensee
Medicine · University of Michigan
- Phoebe A. Tsao
Medicine · University of Michigan
- Arul M. Chinnaiyan
Medicine · University of Michigan
- Jennifer A. Sinnott
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile